rs3742885

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000347230.9(ZFYVE26):​c.3308C>T​(p.Pro1103Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0243 in 1,597,948 control chromosomes in the GnomAD database, including 1,179 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P1103H) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.048 ( 345 hom., cov: 32)
Exomes 𝑓: 0.022 ( 834 hom. )

Consequence

ZFYVE26
ENST00000347230.9 missense

Scores

4
13

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 2.43
Variant links:
Genes affected
ZFYVE26 (HGNC:20761): (zinc finger FYVE-type containing 26) This gene encodes a protein which contains a FYVE zinc finger binding domain. The presence of this domain is thought to target these proteins to membrane lipids through interaction with phospholipids in the membrane. Mutations in this gene are associated with autosomal recessive spastic paraplegia-15. [provided by RefSeq, Oct 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0013165772).
BP6
Variant 14-67785274-G-A is Benign according to our data. Variant chr14-67785274-G-A is described in ClinVar as [Benign]. Clinvar id is 130780.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr14-67785274-G-A is described in Lovd as [Benign]. Variant chr14-67785274-G-A is described in Lovd as [Likely_benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.119 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
ZFYVE26NM_015346.4 linkuse as main transcriptc.3308C>T p.Pro1103Leu missense_variant 19/42 ENST00000347230.9 NP_056161.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
ZFYVE26ENST00000347230.9 linkuse as main transcriptc.3308C>T p.Pro1103Leu missense_variant 19/421 NM_015346.4 ENSP00000251119 P1

Frequencies

GnomAD3 genomes
AF:
0.0484
AC:
7357
AN:
152136
Hom.:
345
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0195
Gnomad ASJ
AF:
0.0130
Gnomad EAS
AF:
0.127
Gnomad SAS
AF:
0.0224
Gnomad FIN
AF:
0.00904
Gnomad MID
AF:
0.0380
Gnomad NFE
AF:
0.0153
Gnomad OTH
AF:
0.0468
GnomAD3 exomes
AF:
0.0307
AC:
6698
AN:
218408
Hom.:
271
AF XY:
0.0285
AC XY:
3357
AN XY:
117862
show subpopulations
Gnomad AFR exome
AF:
0.129
Gnomad AMR exome
AF:
0.0122
Gnomad ASJ exome
AF:
0.0122
Gnomad EAS exome
AF:
0.127
Gnomad SAS exome
AF:
0.0196
Gnomad FIN exome
AF:
0.00827
Gnomad NFE exome
AF:
0.0166
Gnomad OTH exome
AF:
0.0228
GnomAD4 exome
AF:
0.0218
AC:
31453
AN:
1445694
Hom.:
834
Cov.:
32
AF XY:
0.0215
AC XY:
15454
AN XY:
717982
show subpopulations
Gnomad4 AFR exome
AF:
0.119
Gnomad4 AMR exome
AF:
0.0121
Gnomad4 ASJ exome
AF:
0.0131
Gnomad4 EAS exome
AF:
0.132
Gnomad4 SAS exome
AF:
0.0207
Gnomad4 FIN exome
AF:
0.00934
Gnomad4 NFE exome
AF:
0.0158
Gnomad4 OTH exome
AF:
0.0280
GnomAD4 genome
AF:
0.0484
AC:
7370
AN:
152254
Hom.:
345
Cov.:
32
AF XY:
0.0473
AC XY:
3518
AN XY:
74452
show subpopulations
Gnomad4 AFR
AF:
0.121
Gnomad4 AMR
AF:
0.0195
Gnomad4 ASJ
AF:
0.0130
Gnomad4 EAS
AF:
0.127
Gnomad4 SAS
AF:
0.0226
Gnomad4 FIN
AF:
0.00904
Gnomad4 NFE
AF:
0.0153
Gnomad4 OTH
AF:
0.0468
Alfa
AF:
0.0225
Hom.:
211
Bravo
AF:
0.0539
TwinsUK
AF:
0.0178
AC:
66
ALSPAC
AF:
0.0145
AC:
56
ESP6500AA
AF:
0.120
AC:
529
ESP6500EA
AF:
0.0157
AC:
135
ExAC
AF:
0.0303
AC:
3636
Asia WGS
AF:
0.0690
AC:
241
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsAug 02, 2017- -
Likely benign, no assertion criteria providedclinical testingGenetic Services Laboratory, University of Chicago-Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Benign, criteria provided, single submitterclinical testingGeneDxMay 25, 2016This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
not provided Benign:2
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Likely benign, no assertion criteria providedclinical testingLaboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)-- -
Hereditary spastic paraplegia 15 Benign:2
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabDec 05, 2021- -
Spastic paraplegia Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Hereditary spastic paraplegia Benign:1
Benign, criteria provided, single submitterclinical testingGenome Diagnostics Laboratory, The Hospital for Sick ChildrenDec 12, 2016- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.092
BayesDel_addAF
Benign
-0.68
T
BayesDel_noAF
Benign
-0.62
CADD
Benign
19
DANN
Uncertain
0.99
DEOGEN2
Benign
0.0078
.;T
Eigen
Benign
-0.17
Eigen_PC
Benign
-0.095
FATHMM_MKL
Uncertain
0.90
D
LIST_S2
Benign
0.70
.;T
MetaRNN
Benign
0.0013
T;T
MetaSVM
Benign
-1.1
T
MutationTaster
Benign
0.97
D;D
PrimateAI
Benign
0.36
T
PROVEAN
Benign
0.11
N;N
REVEL
Benign
0.065
Sift
Uncertain
0.018
D;D
Sift4G
Uncertain
0.0070
D;D
Polyphen
0.47
.;P
Vest4
0.084
MPC
0.17
ClinPred
0.013
T
GERP RS
4.7
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
gMVP
0.19

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs3742885; hg19: chr14-68251991; COSMIC: COSV61332134; API